Vascular Therapies
Cresskill, US · Delaware corporation · 1 known investors
Founders & leadership
SI
Sriram IyerExecutive
Board
SS
KT
Kiyoshi TakesueBoard director
RF
Robert FlanaganBoard director
AT
Allan TesslerBoard director
MB
Michael BambergerBoard director
GD
Gerald DorrosBoard director
RC
Robert CroceBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$78.5M disclosed across 5 rounds · 2015–2022
▶$24MraisedMar 2022 · 54 investors · BiotechnologyRule 506(b)
▶$24MraisedMar 2022 · 54 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert FlanaganDirector
- Allan TesslerDirector
- Gerald DorrosDirector
- Robert CroceDirector
- Andrew MidlerDirector
- John McDermottExecutive Officer, Director
- Sriram IyerExecutive Officer, Director
- Daniel RyanDirector
- Somu SubramaniamDirector
- Offering amount
- $25.2M
- Amount sold
- $24M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedAug 2021 · 96 investors · BiotechnologyRule 506(b)
▶$3.7MraisedAug 2021 · 96 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John McDermottExecutive Officer, Director
- Robert FlanaganDirector
- Daniel RyanDirector
- Somus SubramaniamDirector
- Sriram IyerDirector
- Andrew MidlerDirector
- Gerald DorrosDirector
- Allan TesslerDirector
- Robert CroceDirector
- Offering amount
- $4M
- Amount sold
- $3.7M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedNov 2019 · 39 investors · BiotechnologyRule 506(b)
▶$7.4MraisedNov 2019 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sriram IyerDirector
- Gerald DorrosDirector
- Allan TesslerDirector
- Robert CroceDirector
- John McDermottExecutive Officer, Director
- Kiyoshi TakesueDirector
- Andrew MidlerDirector
- Robert FlanaganDirector
- Somu SubramaniamDirector
- Daniel RyanDirector
- Offering amount
- $14.8M
- Amount sold
- $7.4M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.4MraisedOct 2018 · 29 investors · BiotechnologyRule 506(b)
▶$12.4MraisedOct 2018 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kiyoshi TakesueDirector
- Robert CroceDirector
- Sriram IyerExecutive Officer, Director
- Allan TesslerDirector
- Dan RyanDirector
- Somu SubramaniamDirector
- Robert FlanaganDirector
- Gerald DorrosDirector
- Andrew MidlerDirector
- Offering amount
- $21.1M
- Amount sold
- $12.4M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$31MraisedDec 2016 · 33 investors · BiotechnologyRule 506(b)
▶$31MraisedDec 2016 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Somu SubramaniamDirector
- Allan TesslerDirector
- Michael BambergerDirector
- Gerald DorrosDirector
- Kiyoshi TakesueDirector
- Sriram IyerExecutive Officer, Director
- Robert CroceDirector
- Robert FlanaganDirector
- Offering amount
- $31M
- Amount sold
- $31M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Vascular Therapies's investors?
- Vascular Therapies's investors include New Science Ventures.
- How much funding has Vascular Therapies raised?
- Vascular Therapies has disclosed $78.5M raised across 5 rounds.
- Where is Vascular Therapies headquartered?
- Vascular Therapies is headquartered in Cresskill, US.